DM1 DMPK

Disease ID
DM1
Gene ID
DMPK
Updated
Jan 23, 2026
v2.14.0
Suggest Edit

Disease

Name
Myotonic dystrophy type 1
Inheritance
Autosomal dominant
Description
Steinert disease, also known as myotonic dystrophy type 1, is a muscle disease characterized by myotonia and by multiorgan damage that combines various degrees of muscle weakness, arrhythmia and/or cardiac conduction disorders, cataract, endocrine damage, sleep disorders and baldness1 . It has also been linked to Autism and related traits, especially in individuals with earlier onset2,3,4,5,6,7 .
Prevalence
9.27 100,000
5-20/100,0008 . 0.5-18.1/100,0009 ; 6.5/100,00010 . 9.27 cases (95% CI: 4.73-15.21) per 100,000, ranging from 0.37 to 36.29 cases per 100,00011 . Found across ethnicities/ancestries, with population-dependent prevalence8 .
Age of Onset(Typical)Years0  7410  30
Age of Onset Details
Typical: 10-308 ; Range: 0-7412 .

Locus

Details
Overview of disease locus through 2024, including largest pathogenic allele of 4,000, described in Rimoldi et al review13 . Intermediate alleles (35-49) associated with premutation8 . 3%-8% of DM1 expansions contain interrupting variant repeats such as CCG and CGG, associated with later onset and milder phenotype; the variant repeat GCGGCA has also been reported14,15 . In another study, interruptions of the CTG repeat with CCG, GGC, CTC or CAG motifs are estimated to occur in 3-11% of DM1 patients16 . Expansions within gene ZNF850 may function as DM1 modifiers17 .
Mechanism
GoF
RNA gain-of-function: RNA gelation leading to misregulation of alternative splicing18 . Expanded-repeat RNA sequesters the muscleblind-like (MBNL) family of RNA-binding proteins as part of the disruption of pre-mRNA processing, contributing to cardiac phenotypes19 . Loss of MBNL proteins has been linked to mis-splicing of Autism spectrum-risk genes such as SCN2A, ANK2, and SHANK2, possibly leading to Autism-related traits2
Year
199220
Location in Gene
3' UTR
Gene Strand

Alleles

Ref. Motif
CAG
Pathogenic (ref.)
CAG
Pathogenic (gene)
CTG
BenignIntermediatePathogenicUnits5  3435  4950  4,000

gnomAD

References

Direct supporting references for info on this page.

1
Ontology Lookup Service (OLS)
mondo:0008056
2
Autism-related traits in myotonic dystrophy type 1 model mice are due to MBNL sequestration and RNA mis-splicing of autism-risk genes.
Łukasz J,Sznajder, Mahreen,Khan, Adam,Ciesiołka, Mariam,Tadross, Curtis A,Nutter, Katarzyna,Taylor, Christopher E,Pearson, Mark H,Lewis, Rochelle M,Hines, Maurice S,Swanson, Krzysztof,Sobczak, Ryan K C,Yuen
Nature neuroscience · 2025-04-21
pmid:40259070
3
Childhood-onset form of myotonic dystrophy type 1 and autism spectrum disorder: Is there comorbidity?
N,Angeard, E,Huerta, A,Jacquette, D,Cohen, J,Xavier, M,Gargiulo, L,Servais, B,Eymard, D,Héron
Neuromuscular disorders : NMD · 2017-12-15
pmid:29361396
4
Asperger syndrome associated with Steinert's myotonic dystrophy.
T A,Blondis, E,Cook, P,Koza-Taylor, T,Finn
Developmental medicine and child neurology · 1996-09-01
pmid:8810716
5
Expanded
Zuzana,Musova, Miroslava,Hancarova, Marketa,Havlovicova, Radka,Pourova, Michal,Hrdlicka, Josef,Kraus, Marie,Trkova, David,Stejskal, Zdenek,Sedlacek
Neuropsychiatric disease and treatment · 2016-09-19
pmid:27695335
6
Myotonic dystrophy type 1: clinical manifestations in children and adolescents.
Genevieve,Ho, Kate A,Carey, Michael,Cardamone, Michelle A,Farrar
Archives of disease in childhood · 2018-06-05
pmid:29871899
7
Cognitive function, behaviour and quality of life in children with myotonic dystrophy type 1 in South - Eastern Norway.
Petra,Aden, Anne-Britt,Skarbø, Sean,Wallace, Kristin,Ørstavik, Magnhild,Rasmussen
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society · 2023-05-13
pmid:37209486
8
Myotonic Dystrophy Type 1
Thomas D.,Bird
GeneReviews® · 1993-01-01
genereviews:NBK1165
9
Profiling of Short-Tandem-Repeat Disease Alleles in 12,632 Human Whole Genomes.
Haibao,Tang, Ewen F,Kirkness, Christoph,Lippert, William H,Biggs, Martin,Fabani, Ernesto,Guzman, Smriti,Ramakrishnan, Victor,Lavrenko, Boyko,Kakaradov, Claire,Hou, Barry,Hicks, David,Heckerman, Franz J,Och, C Thomas,Caskey, J Craig,Venter, Amalio,Telenti
American journal of human genetics · 2017-11-02
pmid:29100084
10
The DM-scope registry: a rare disease innovative framework bridging the gap between research and medical care.
Marie,De Antonio, Céline,Dogan, Ferroudja,Daidj, Bruno,Eymard, Jack,Puymirat, Jean,Mathieu, Cynthia,Gagnon, Sandrine,Katsahian, Dalil,Hamroun, Guillaume,Bassez
Orphanet journal of rare diseases · 2019-06-03
pmid:31159885
11
Global Prevalence of Myotonic Dystrophy: An Updated Systematic Review and Meta-Analysis.
Qiao,Liao, Yihao,Zhang, Jian,He, Kun,Huang
Neuroepidemiology · 2022-04-28
pmid:35483324
12
Clinical features and genetic spectrum of a multicenter Chinese cohort with myotonic dystrophy type 1.
Huahua,Zhong, Li,Zeng, Xuefan,Yu, Qing,Ke, Jihong,Dong, Yan,Chen, Lijun,Luo, Xueli,Chang, Junhong,Guo, Yiqi,Wang, Hui,Xiong, Rongrong,Liu, Changxia,Liu, Jibao,Wu, Jie,Lin, Jianying,Xi, Wenhua,Zhu, Song,Tan, Fuchen,Liu, Jiahong,Lu, Chongbo,Zhao, Sushan,Luo
Orphanet journal of rare diseases · 2024-03-07
pmid:38454488
13
Myotonic dystrophies: an update on clinical features, molecular mechanisms, management, and gene therapy.
Martina,Rimoldi, Sabrina,Lucchiari, Serena,Pagliarani, Giovanni,Meola, Giacomo Pietro,Comi, Elena,Abati
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024-12-07
pmid:39643839
14
Variant repeats within the
Jacob N,Miller, Ellen,van der Plas, Mark,Hamilton, Timothy R,Koscik, Laurie,Gutmann, Sarah A,Cumming, Darren G,Monckton, Peggy C,Nopoulos
Neurology. Genetics · 2020-08-12
pmid:32851192
15
Advancing molecular diagnostics of myotonic dystrophy type 1 using short-read whole genome sequencing
Ingrid,Lojova, Marcel,Kucharik, Zuzana,Pös, Andrej,Balaz, Andrea,Zatkova, Eva,Tothova Tarova, Jaroslav,Budis, Ludevit,Kadasi, Tomas,Szemes, Jan,Radvanszky
Molecular and Cellular Probes · 2025-02-01
doi:10.1016/j.mcp.2024.102005
16
High Resolution Analysis of
Astrid,Rasmussen, Mathis,Hildonen, John,Vissing, Morten,Duno, Zeynep,Tümer, Ulf,Birkedal
Genes · 2022-05-28
pmid:35741732
17
Identification of ZNF850 as a novel CTG repeat expansion-related gene in myotonic dystrophy type 1 patient-derived iPSCs
Masayoshi,Kamon, Shuji,Wakatsuki, Masayuki,Nakamori, Masanori P,Takahashi, Madoka,Mori-Yoshimura, Hirofumi,Komaki, Toshiyuki,Araki
Human Molecular Genetics · 2024-12-16
doi:10.1093/hmg/ddae186
18
Clinical and neuroimaging review of triplet repeat diseases.
Ryo,Kurokawa, Mariko,Kurokawa, Akihiko,Mitsutake, Moto,Nakaya, Akira,Baba, Yasuhiro,Nakata, Toshio,Moritani, Osamu,Abe
Japanese journal of radiology · 2022-09-28
pmid:36169768
19
MBNL overexpression rescues cardiac phenotypes in a myotonic dystrophy type 1 heart mouse model.
Rong-Chi,Hu, Yi,Zhang, Larissa,Nitschke, Sara J,Johnson, Ayrea E,Hurley, William R,Lagor, Zheng,Xia, Thomas A,Cooper
The Journal of clinical investigation · 2025-02-11
pmid:39932794
20
Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.
J D,Brook, M E,McCurrach, H G,Harley, A J,Buckler, D,Church, H,Aburatani, K,Hunter, V P,Stanton, J P,Thirion, T,Hudson
Cell · 1992-02-21
pmid:1310900

Additional Literature

Additional literature related to this locus.

Raw PubMed search results
(All PubMed results returned by searching for this gene, tandem repeats, and disease, in medline format)

MBNL loss of function in smooth muscle as a model for myotonic dystrophy associated gastrointestinal dysmotility.
Janel A M,Peterson, Jesus A,Frias, Andrew N,Miller, Krishnakant G,Soni, Yi,Zhang, Zheng,Xia, John W,Day, Geoffrey A,Preidis, Thomas A,Cooper
Proceedings of the National Academy of Sciences of the United States of America · 2025-12-11
pmid:41379996
Potential of Nanopore Long Read Sequencing for Determining CTG Repeat Lengths in the DMPK1 Gene During Prenatal or Preimplantation Genetic Testing.
Yui,Shichiri, Hidehito,Inagaki, Tasuku,Mariya, Yuri,Murase, Takeshi,Sugimoto, Eiji,Sugihara, Haruki,Nishizawa, Hiroki,Kurahashi
Prenatal diagnosis · 2025-11-19
pmid:41260620
Alternative Splicing of SORBS1 Affects Neuromuscular Junction Integrity in Myotonic Dystrophy Type 1.
Caroline,Hermitte, Hortense,de Calbiac, Gilles,Moulay, Antoine,Mérien, Jeanne,Lainé, Hélène,Polvèche, Michel,Cailleret, Stéphane,Vassilopoulos, Edor,Kabashi, Denis,Furling, Cécile,Martinat, Morgan,Gazzola
Journal of cachexia, sarcopenia and muscle · 2025-12-01
pmid:41250834
HSA
Dusan M,Lazic, Vladimir M,Jovanovic, Jelena,Karanovic, Dusanka,Savic-Pavicevic, Bogdan,Jovanovic
International journal of molecular sciences · 2025-11-06
pmid:41226829
Aberrant Splicing of
Oluwafolajimi,Adesanya, Pouya,Nabie, Alexandra,Betancourt, Auinash,Kalsotra
Circulation. Genomic and precision medicine · 2025-11-10
pmid:41212113
Analysis of muscle and blood RNA samples from patients with myotonic dystrophy type 1 reveals the presence of new mis-splicing biomarkers of disease severity.
Melissa,Palma-Jiménez, Lisbeth,Ramirez-Carvajal, Eyleen,Corrales, Hailey,Olafson, Eric T,Wang, Fernando,Morales
Journal of medical genetics · 2025-12-04
pmid:41161721
Association of Non-Coding Repeat Expansions with Parkinson's Disease Risk: Evidence from a UK Biobank-Based Whole-Genome Sequencing Study.
Zhen,Hu, Qin-Qin,Yan, Jing-Jin,Wan, Yu,Fan, Jun,Liu
Movement disorders : official journal of the Movement Disorder Society · 2025-10-11
pmid:41074692
Development of an AAV-delivered microRNA gene therapy for myotonic dystrophy type 1.
Giulio S,Tomassy, Wei,Fan, Shuwen,Cao, Zhengyu,Luo, Alessandro,Magli, Tracy,Zhang, Kristen,Boyle, Robert,Jackson, Brenda,Richards, Dongyu,Liu, Franck,Rapaport, Shameer,Khader, Edith L,Pfister, Catherine,O'Riordan, Amy,Frederick, Jennifer,Sullivan, James,Cao, Kollu,Nageswara Rao, Basel T,Assaf, Martin,Goulet, Christian,Mueller
Molecular therapy : the journal of the American Society of Gene Therapy · 2025-09-02
pmid:40903903
circARHGAP10 as a candidate biomarker and therapeutic target in myotonic dystrophy type 1.
Denisa,Baci, Spyros,Tastsoglou, Claudia,Provenzano, Alessandra,Perfetti, Mariapaola,Izzo, Mario,Lisanti, Svetlana,Frolova, Christine,Voellenkle, Anna Sofia,Tascini, Rosanna,Cardani, Beatrice,Cardinali, Giovanni,Meola, Germana,Falcone, Fabio,Martelli
Molecular therapy. Nucleic acids · 2025-07-30
pmid:40896579